Michael Bethel

Company: Biogen

Job title: Global Head of Access Mechanisms

Seminars:

Evaluating the Shift to Named Patient & Paid-For Programs: Ethical & Practical Considerations 2:45 pm

Exploring the reasons for switching to a named-patient program, including the potential benefits of generating revenue through such models Delving into the ethical implications and governance processes required when transitioning from compassionate use to paid-for programs Learning strategies to address the challenges that arise when a drug is approved in one country but patients in…Read more

day: Conference Day Two